메뉴 건너뛰기




Volumn 31, Issue 5, 2009, Pages 463-466

A long-term follow-up of botulinum toxin a in cervical dystonia

Author keywords

Botulinum toxin; Cervical dystonia; Long term follow up

Indexed keywords

BOTULINUM TOXIN A; NEUTRALIZING ANTIBODY;

EID: 67650178786     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X405137     Document Type: Article
Times cited : (70)

References (29)
  • 1
    • 0023757658 scopus 로고
    • Epidemiology of dystonia in Rochester, Minnesota
    • Nutt JG, Muenter MD, Melton LJ, 3rd, et al. Epidemiology of dystonia in Rochester, Minnesota. Adv Neurol 1988; 50: 361-365
    • (1988) Adv Neurol , vol.50 , pp. 361-365
    • Nutt, J.G.1    Muenter, M.D.2    Melton III, L.J.3
  • 2
    • 0034917328 scopus 로고    scopus 로고
    • Health related quality of life is improved by botulinum neurotoxin type a in long term treated patients with focal dystonia
    • Hilker R, Schischniaschvili M, Ghaemi M, et al. Health related quality of life is improved by botulinum neurotoxin type a in long term treated patients with focal dystonia. J Neurol Neurosurg Psychiatry 2001; 71: 193-199
    • (2001) J Neurol Neurosurg Psychiatry , vol.71 , pp. 193-199
    • Hilker, R.1    Schischniaschvili, M.2    Ghaemi, M.3
  • 3
    • 0036651242 scopus 로고    scopus 로고
    • Impact of cervical dystonia on quality of life
    • Camfield L, Ben-Shlomo Y, Warner TT. Impact of cervical dystonia on quality of life. Mov Disord 2002; 17: 838-841
    • (2002) Mov Disord , vol.17 , pp. 838-841
    • Camfield, L.1    Ben-Shlomo, Y.2    Warner, T.T.3
  • 4
    • 0036240889 scopus 로고    scopus 로고
    • What are the determinants of quality of life in people with cervical dystonia?
    • Ben-Shlomo Y, Camfield L, Warner T. What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry 2002; 72: 608-614
    • (2002) J Neurol Neurosurg Psychiatry , vol.72 , pp. 608-614
    • Ben-Shlomo, Y.1    Camfield, L.2    Warner, T.3
  • 5
    • 0022337622 scopus 로고
    • A pilot study on the use of botulinum toxin in spasmodic torticollis
    • Tsui JK, Eisen A, Mak E, et al. A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci 1985; 12: 314-316
    • (1985) Can J Neurol Sci , vol.12 , pp. 314-316
    • Tsui, J.K.1    Eisen, A.2    Mak, E.3
  • 6
    • 0022587865 scopus 로고
    • Double-blind study of botulinum toxin in spasmodic torticollis
    • Tsui JK, Eisen A, Stoessl AJ, et al. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet 1986; 2: 245-247
    • (1986) Lancet , vol.2 , pp. 245-247
    • Tsui, J.K.1    Eisen, A.2    Stoessl, A.J.3
  • 7
    • 0036869216 scopus 로고    scopus 로고
    • Long-term efficacy of botulinum toxin a in treatment of various movement disorders over a 10-year period
    • Hsiung GY, Das SK, Ranawaya R, et al. Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Mov Disord 2002; 17: 1288-1293
    • (2002) Mov Disord , vol.17 , pp. 1288-1293
    • Hsiung, G.Y.1    Das, S.K.2    Ranawaya, R.3
  • 8
    • 14044254756 scopus 로고    scopus 로고
    • The course of cervical dystonia and patient satisfaction with long-term botulinum toxin a treatment
    • Skogseid IM, Kerty E. The course of cervical dystonia and patient satisfaction with long-term botulinum toxin a treatment. Eur J Neurol 2005; 12: 163-170
    • (2005) Eur J Neurol , vol.12 , pp. 163-170
    • Skogseid, I.M.1    Kerty, E.2
  • 9
    • 3042635460 scopus 로고    scopus 로고
    • Long-term follow-up of cervical dystonia patients treated with botulinum toxin A
    • Haussermann P, Marczoch S, Klinger C, et al. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A. Mov Disord 2004; 19: 303-308
    • (2004) Mov Disord , vol.19 , pp. 303-308
    • Haussermann, P.1    Marczoch, S.2    Klinger, C.3
  • 10
    • 20844447349 scopus 로고    scopus 로고
    • Long-term botulinum toxin efficacy, safety, and immunogenicity
    • Mejia NI, Vuong KD, Jankovic J. Long-term botulinum toxin efficacy, safety, and immunogenicity. Mov Disord 2005; 20: 592-597
    • (2005) Mov Disord , vol.20 , pp. 592-597
    • Mejia, N.I.1    Vuong, K.D.2    Jankovic, J.3
  • 11
    • 0028803612 scopus 로고
    • Response and immunoresistance to botulinum toxin injections
    • Jankovic J, Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology 1995; 45: 1743-1746
    • (1995) Neurology , vol.45 , pp. 1743-1746
    • Jankovic, J.1    Schwartz, K.2
  • 12
    • 0033957251 scopus 로고    scopus 로고
    • Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type a under EMG guidance. An open label study
    • Rollnik JD, Matzke M, Wohlfarth K, et al. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type a under EMG guidance. An open label study. Eur Neurol 2000; 43: 9-12
    • (2000) Eur Neurol , vol.43 , pp. 9-12
    • Rollnik, J.D.1    Matzke, M.2    Wohlfarth, K.3
  • 13
    • 0031239673 scopus 로고    scopus 로고
    • Botulinum a toxin therapy: Neutralizing and nonneutralizing antibodies - Therapeutic consequences
    • Goschel H, Wohlfarth K, Frevert J, et al. Botulinum a toxin therapy: Neutralizing and nonneutralizing antibodies - therapeutic consequences. Exp Neurol 1997; 147: 96-102
    • (1997) Exp Neurol , vol.147 , pp. 96-102
    • Goschel, H.1    Wohlfarth, K.2    Frevert, J.3
  • 14
    • 33747161909 scopus 로고    scopus 로고
    • Botulinum toxin therapy for cervical dystonia
    • Jankovic J. Botulinum toxin therapy for cervical dystonia. Neurotox Res 2006; 9: 145-148
    • (2006) Neurotox Res , vol.9 , pp. 145-148
    • Jankovic, J.1
  • 15
    • 26444491206 scopus 로고    scopus 로고
    • Retrospective evaluation of the dose of dysport and botox in the management of cervical dystonia and blepharospasm: The real dose study
    • Marchetti A, Magar R, Findley L, et al. Retrospective evaluation of the dose of dysport and botox in the management of cervical dystonia and blepharospasm: The real dose study. Mov Disord 2005; 20: 937-944
    • (2005) Mov Disord , vol.20 , pp. 937-944
    • Marchetti, A.1    Magar, R.2    Findley, L.3
  • 16
    • 0032951652 scopus 로고    scopus 로고
    • Long-term treatment of cervical dystonia with botulinum toxin a: Efficacy, safety, and antibody frequency. German Dystonia Study Group
    • Kessler KR, Skutta M, Benecke R. Long-term treatment of cervical dystonia with botulinum toxin a: Efficacy, safety, and antibody frequency. German Dystonia Study Group. J Neurol 1999; 246: 265-274
    • (1999) J Neurol , vol.246 , pp. 265-274
    • Kessler, K.R.1    Skutta, M.2    Benecke, R.3
  • 17
    • 49249129595 scopus 로고    scopus 로고
    • Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin a
    • Vogt T, Lussi F, Paul A, et al. [Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin a]. Der Nervenarzt 2008; 79: 912-917
    • (2008) Der Nervenarzt , vol.79 , pp. 912-917
    • Vogt, T.1    Lussi, F.2    Paul, A.3
  • 18
    • 0037066095 scopus 로고    scopus 로고
    • Accuracy of muscle localization without EMG: Implications for treatment of limb dystonia
    • Molloy FM, Shill HA, Kaelin-Lang A, et al. Accuracy of muscle localization without EMG: Implications for treatment of limb dystonia. Neurology 2002; 58: 805-807
    • (2002) Neurology , vol.58 , pp. 805-807
    • Molloy, F.M.1    Shill, H.A.2    Kaelin-Lang, A.3
  • 19
    • 17844394143 scopus 로고    scopus 로고
    • Accuracy of intramuscular injection of botulinum toxin a in juvenile cerebral palsy: A comparison between manual needle placement and placement guided by electrical stimulation
    • Chin TY, Nattrass GR, Selber P, et al. Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: A comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 2005; 25: 286-291
    • (2005) J Pediatr Orthop , vol.25 , pp. 286-291
    • Chin, T.Y.1    Nattrass, G.R.2    Selber, P.3
  • 20
    • 0025886672 scopus 로고
    • A double blind trial of botulinum toxin 'A' in torticollis, with one year follow up
    • Moore AP, Blumhardt LD. A double blind trial of botulinum toxin 'A' in torticollis, with one year follow up. J Neurol Neurosurg Psychiatry 1991; 54: 813-816
    • (1991) J Neurol Neurosurg Psychiatry , vol.54 , pp. 813-816
    • Moore, A.P.1    Blumhardt, L.D.2
  • 21
    • 24144445115 scopus 로고    scopus 로고
    • Efficacy and safety of botulinum type a toxin (dysport) in cervical dystonia: Results of the first us randomized, double-blind, placebo-controlled study
    • Truong D, Duane DD, Jankovic J, et al. Efficacy and safety of botulinum type a toxin (dysport) in cervical dystonia: Results of the first us randomized, double-blind, placebo-controlled study. Mov Disord 2005; 20: 783-791
    • (2005) Mov Disord , vol.20 , pp. 783-791
    • Truong, D.1    Duane, D.D.2    Jankovic, J.3
  • 22
    • 6844266275 scopus 로고    scopus 로고
    • What is the optimal dose of botulinum toxin a in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using dysport. German Dystonia Study Group
    • Poewe W, Deuschl G, Nebe A, et al. What is the optimal dose of botulinum toxin a in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry 1998; 64: 13-17
    • (1998) J Neurol Neurosurg Psychiatry , vol.64 , pp. 13-17
    • Poewe, W.1    Deuschl, G.2    Nebe, A.3
  • 23
    • 0027421580 scopus 로고
    • Botulinum antibodies in dystonic patients treated with type a botulinum toxin: Frequency and significance
    • Zuber M, Sebald M, Bathien N, et al. Botulinum antibodies in dystonic patients treated with type a botulinum toxin: Frequency and significance. Neurology 1993; 43: 1715-1718
    • (1993) Neurology , vol.43 , pp. 1715-1718
    • Zuber, M.1    Sebald, M.2    Bathien, N.3
  • 24
    • 0028345811 scopus 로고
    • Development of resistance to botulinum toxin type a in patients with torticollis
    • Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 1994; 9: 213-217
    • (1994) Mov Disord , vol.9 , pp. 213-217
    • Greene, P.1    Fahn, S.2    Diamond, B.3
  • 25
    • 0026787576 scopus 로고
    • Stabilization of botulinum toxin type a during lyophilization
    • Goodnough MC, Johnson EA. Stabilization of botulinum toxin type A during lyophilization. Appl Environ Microbiol 1992; 58: 3426-3428
    • (1992) Appl Environ Microbiol , vol.58 , pp. 3426-3428
    • Goodnough, M.C.1    Johnson, E.A.2
  • 26
    • 0033378779 scopus 로고    scopus 로고
    • Preclinical update on Botox (botulinum toxin type a)-purified neurotoxin complex relative to other botulinum neurotoxin preparations
    • Aoki K. Preclinical update on Botox (botulinum toxin type a)-purified neurotoxin complex relative to other botulinum neurotoxin preparations. Eur J Neurol 1999; 6 (Suppl. 4): S3-S10
    • (1999) Eur J Neurol , vol.6 , Issue.SUPPL. 4
    • Aoki, K.1
  • 27
    • 0037426445 scopus 로고    scopus 로고
    • Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia
    • Jankovic J, Vuong KD, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology 2003; 60: 1186-1188
    • (2003) Neurology , vol.60 , pp. 1186-1188
    • Jankovic, J.1    Vuong, K.D.2    Ahsan, J.3
  • 28
    • 41249097564 scopus 로고    scopus 로고
    • Treatment of dystonia with deep brain stimulation
    • Ostrem JL, Starr PA. Treatment of dystonia with deep brain stimulation. Neurotherapeutics 2008; 5: 320-330
    • (2008) Neurotherapeutics , vol.5 , pp. 320-330
    • Ostrem, J.L.1    Starr, P.A.2
  • 29
    • 0000170999 scopus 로고
    • Clinical assessments of patients with cervical dystonia
    • Jankovic J, Hallett M, eds. New York: Marcel Dekker
    • Consky ES, Lang AE. Clinical assessments of patients with cervical dystonia. In: Jankovic J, Hallett M, eds. Therapy with Botulinum Toxin, New York: Marcel Dekker, 1994: pp. 211-237
    • (1994) Therapy with Botulinum Toxin , pp. 211-237
    • Consky, E.S.1    Lang, A.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.